BELLUS Health Inc. (BLU)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3700-0.0500 (-1.46%)
At close: 4:00PM EDT
| Previous close | 3.4200 |
| Open | 3.3800 |
| Bid | 3.3500 x 800 |
| Ask | 3.3900 x 800 |
| Day's range | 3.3200 - 3.4350 |
| 52-week range | 2.0100 - 12.0300 |
| Volume | 203,873 |
| Avg. volume | 533,881 |
| Market cap | 265.833M |
| Beta (5Y monthly) | -0.57 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 11 Aug 2021 - 16 Aug 2021 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
New Strong Sell Stocks for May 25th
AJRD, BLU, GMBL, LITE, and PSXP have been added to the Zacks Rank #5 (Strong Sell) List on May 25, 2021
- Business Wire
BELLUS Health to Participate in the Jefferies Virtual Healthcare Conference
BELLUS Health Inc. (Nasdaq:BLU; TSX:BLU) ("BELLUS Health" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of refractory chronic cough ("RCC") and other hypersensitization-related disorders, today announced that Roberto Bellini, BELLUS Health's President and Chief Executive Officer, will be participating in a fireside chat at the Jefferies Virtual Healthcare Conference.
- Zacks
New Strong Sell Stocks for May 18th
AFYA, BLU, CHRA, DHX, and EBMT have been added to the Zacks Rank #5 (Strong Sell) List on May 18, 2021
© 2021 Verizon Media. All rights reserved.
